secwatch.observer — SEC 8-K summary
======================================

Issuer:     Innovation1 Biotech Inc. (—)
CIK:        0001629205
Form:       8-K
Filed at:   2023-09-08T23:59:59+00:00
Accession:  0001477932-23-006754
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Innovation1 Biotech closes $78,695 secured convertible note + warrant financing
-------------------------------------------------------------------------------

- Gross proceeds of $66,891 from $78,695 principal amount 8% secured convertible notes due Sept 30, 2024.
- Notes convertible at $0.08/share; 983,693 warrants issued with $0.08 exercise price.
- Transaction completed with two purchasers; securities unregistered under Rule 506(b).
- Notes include 4.99% beneficial ownership limitation and secured by company assets.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1629205/000147793223006754/0001477932-23-006754-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1629205/000147793223006754/ivbt_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-006754

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer